Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bell, 2010, Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging, Neuron, 68, 409, 10.1016/j.neuron.2010.09.043
Göritz, 2011, A pericyte origin of spinal cord scar tissue, Science, 333, 238, 10.1126/science.1203165
Peppiatt, 2006, Bidirectional control of CNS capillary diameter by pericytes, Nature, 443, 700, 10.1038/nature05193
Oyinbo, 2011, Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade, Acta Neurobiol Exp (Wars), 71, 281, 10.55782/ane-2011-1848
Beck, 2010, Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment, Brain, 133, 433, 10.1093/brain/awp322
Fleming, 2006, The cellular inflammatory response in human spinal cords after injury, Brain, 129, 3249, 10.1093/brain/awl296
Sroga, 2003, Rats and mice exhibit distinct inflammatory reactions after spinal cord injury, J Comp Neurol, 462, 223, 10.1002/cne.10736
Soderblom, 2013, Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury, Journal of Neuroscience, 33, 13882, 10.1523/JNEUROSCI.2524-13.2013
Bruce, 2000, Schwannosis: role of gliosis and proteoglycan in human spinal cord injury, J Neurotrauma, 17, 781, 10.1089/neu.2000.17.781
Buss, 2007, Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury, Brain, 130, 940
Zhang, 2013, Role of endogenous Schwann cells in tissue repair after spinal cord injury, Neural Regen Res, 8, 177
Beattie, 1997, Endogenous repair after spinal cord contusion injuries in the rat, Exp Neurol, 148, 453, 10.1006/exnr.1997.6695
Anderson, 2016, Astrocyte scar formation aids central nervous system axon regeneration, Nature, 532, 195, 10.1038/nature17623
Burda, 2014, Reactive gliosis and the multicellular response to CNS damage and disease, Neuron, 81, 229, 10.1016/j.neuron.2013.12.034
Zhu, 2014, Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury, Neurobiol Dis, 74C, 114
Zamanian, 2012, Genomic analysis of reactive astrogliosis, Journal of Neuroscience, 32, 6391, 10.1523/JNEUROSCI.6221-11.2012
David, 1981, Axonal elongation into peripheral nervous system “bridges” after central nervous system injury in adult rats, Science, 214, 931, 10.1126/science.6171034
Abnet, 1991, Interactions between meningeal cells and astrocytes in vivo and in vitro, Brain Res. Dev. Brain Res, 59, 187, 10.1016/0165-3806(91)90099-5
Bundesen, 2003, Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats, Journal of Neuroscience, 23, 7789, 10.1523/JNEUROSCI.23-21-07789.2003
Shearer, 2001, The astrocyte/meningeal cell interface—a barrier to successful nerve regeneration?, Cell Tissue Res, 305, 267, 10.1007/s004410100384
Kimura-Kuroda, 2010, An in vitro model of the inhibition of axon growth in the lesion scar formed after central nervous system injury, Mol. Cell. Neurosci, 43, 177, 10.1016/j.mcn.2009.10.008
Kawano, 2012, Role of the lesion scar in the response to damage and repair of the central nervous system, Cell Tissue Res, 349, 169, 10.1007/s00441-012-1336-5
Bradbury, 2002, Chondroitinase ABC promotes functional recovery after spinal cord injury, Nature, 416, 636, 10.1038/416636a
Tang, 2003, Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue, J Neurosci Res, 71, 427, 10.1002/jnr.10523
McKeon, 1999, The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar, Journal of Neuroscience, 19, 10778, 10.1523/JNEUROSCI.19-24-10778.1999
Zhu, 2015, Fibronectin matrix assembly after spinal cord injury, J Neurotrauma, 32, 1158, 10.1089/neu.2014.3703
Schreiber, 2013, Extracellular matrix alterations, accelerated leukocyte infiltration and enhanced axonal sprouting after spinal cord hemisection in tenascin-C-deficient mice, Acta Histochem, 115, 865, 10.1016/j.acthis.2013.04.009
Weidner, 1999, Elimination of basal lamina and the collagen “scar” after spinal cord injury fails to augment corticospinal tract regeneration, Exp Neurol, 160, 40, 10.1006/exnr.1999.7200
Klapka, 2005, Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery, Eur J Neurosci, 22, 3047, 10.1111/j.1460-9568.2005.04495.x
Loy, 2002, Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat, J Comp Neurol, 445, 308, 10.1002/cne.10168
Klapka, 2006, Collagen matrix in spinal cord injury, J Neurotrauma, 23, 422, 10.1089/neu.2006.23.422
Ruschel, 2015, Axonal regeneration. Systemic administration of epothilone B promotes axon regeneration after spinal cord injury, Science, 348, 347, 10.1126/science.aaa2958
McKeon, 1991, Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes, J Neurosci, 11, 3398, 10.1523/JNEUROSCI.11-11-03398.1991
Stichel, 1999, Basal membrane-depleted scar in lesioned CNS: characteristics and relationships with regenerating axons, Neuroscience, 93, 321, 10.1016/S0306-4522(99)00112-8
Donnelly, 2008, Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury, Exp Neurol, 209, 378, 10.1016/j.expneurol.2007.06.009
Mawhinney, 2012, Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice, J Neuropathol Exp Neurol, 71, 180, 10.1097/NEN.0b013e3182479b41
Kigerl, 2009, Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord, Journal of Neuroscience, 29, 13435, 10.1523/JNEUROSCI.3257-09.2009
Carlson, 1998, Acute inflammatory response in spinal cord following impact injury, Exp Neurol, 151, 77, 10.1006/exnr.1998.6785
Taoka, 1997, Role of neutrophils in spinal cord injury in the rat, Neuroscience, 79, 1177, 10.1016/S0306-4522(97)00011-0
Popovich, 1999, Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury, Exp Neurol, 158, 351, 10.1006/exnr.1999.7118
Wang, 2013, Microglia/macrophage polarization dynamics in white matter after traumatic brain injury, J Cereb Blood Flow Metab, 33, 1864, 10.1038/jcbfm.2013.146
Fitch, 1999, Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma, J Neurosci, 19, 8182, 10.1523/JNEUROSCI.19-19-08182.1999
Soderblom, 2015, 3D imaging of axons in transparent spinal cords from rodents and nonhuman primates, eNeuro, 2, 10.1523/ENEURO.0001-15.2015
Decimo, 2011, Nestin- and doublecortin-positive cells reside in adult spinal cord meninges and participate in injury-induced parenchymal reaction, STEM CELLS, 29, 2062, 10.1002/stem.766
Zhang, 2015, Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury, J Neuroinflammation, 12, 218, 10.1186/s12974-015-0440-3
Bloom, 2014, Non-mammalian model systems for studying neuro-immune interactions after spinal cord injury, Exp Neurol, 258, 130, 10.1016/j.expneurol.2013.12.023
Goldshmit, 2012, Fgf-dependent glial cell bridges facilitate spinal cord regeneration in zebrafish, Journal of Neuroscience, 32, 7477, 10.1523/JNEUROSCI.0758-12.2012
Zukor, 2011, Meningeal cells and glia establish a permissive environment for axon regeneration after spinal cord injury in newts, Neural Dev, 6, 1, 10.1186/1749-8104-6-1
Logan, 1994, Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat, Eur J Neurosci, 6, 355, 10.1111/j.1460-9568.1994.tb00278.x
East, 2009, A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis, J Tissue Eng Regen Med, 3, 634, 10.1002/term.209
Renault-Mihara, 2017, Regulation of RhoA by STAT3 coordinates glial scar formation, J Cell Biol, 216, 2533, 10.1083/jcb.201610102
Wanner, 2013, Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury, Journal of Neuroscience, 33, 12870, 10.1523/JNEUROSCI.2121-13.2013
Faulkner, 2004, Reactive astrocytes protect tissue and preserve function after spinal cord injury, J Neurosci, 24, 2143, 10.1523/JNEUROSCI.3547-03.2004
Bott, 2010, The effect of matrix characteristics on fibroblast proliferation in 3D gels, Biomaterials, 31, 8454, 10.1016/j.biomaterials.2010.07.046
Harris, 2017, Nerve guidance by a decellularized fibroblast extracellular matrix, Matrix Biol, 60-61, 176, 10.1016/j.matbio.2016.08.011
Franze, 2013, Mechanics in neuronal development and repair, Annu Rev Biomed Eng, 15, 227, 10.1146/annurev-bioeng-071811-150045
Tremble, 1994, The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts, Mol. Biol. Cell, 5, 439, 10.1091/mbc.5.4.439
Trebaul, 2007, Regulation of fibroblast migration by tenascin-C, Biochem. Soc. Trans, 35, 695, 10.1042/BST0350695
Kalembeyi, 2003, Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1, Int. J. Cancer, 105, 53, 10.1002/ijc.11037
Ogier, 2006, Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins, Glia, 54, 272, 10.1002/glia.20349
Goussev, 2003, Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing, J. Neurosurg, 99, 188
Tezel, 2001, In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head, Glia, 34, 178, 10.1002/glia.1052
Takenaga, 2006, Role of intracellular S100A4 for migration of rat astrocytes, Glia, 53, 313, 10.1002/glia.20284
Yu, 2008, Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury, J Neurotrauma, 25, 184, 10.1089/neu.2007.0438
Hsu, 2006, Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury, Journal of Neuroscience, 26, 9841, 10.1523/JNEUROSCI.1993-06.2006
Zhang, 2011, Matrix metalloproteinase-9 and stromal cell-derived factor-1 act synergistically to support migration of blood-borne monocytes into the injured spinal cord, Journal of Neuroscience, 31, 15894, 10.1523/JNEUROSCI.3943-11.2011
Shechter, 2011, The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair, PLoS ONE, 6, 10.1371/journal.pone.0027969
Rolls, 2008, Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation, PLoS Med, 5, e171, 10.1371/journal.pmed.0050171
Tasdemir-Yilmaz, 2014, Astrocytes engage unique molecular programs to engulf pruned neuronal debris from distinct subsets of neurons, Genes Dev, 28, 20, 10.1101/gad.229518.113
Clark, 1993, Growth cone guidance and neuron morphology on micropatterned laminin surfaces, Journal of Cell Science, 105, 203, 10.1242/jcs.105.1.203
Chung, 2013, Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways, Nature, 504, 394, 10.1038/nature12776
Bush, 1999, Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice, Neuron, 23, 297, 10.1016/S0896-6273(00)80781-3
Alilain, 2011, Functional regeneration of respiratory pathways after spinal cord injury, Nature, 475, 196, 10.1038/nature10199
Manwaring, 2004, Contact guidance induced organization of extracellular matrix, Biomaterials, 25, 3631, 10.1016/j.biomaterials.2003.10.043
Gonzalez-Perez, 2013, Extracellular matrix components in peripheral nerve regeneration, Int. Rev. Neurobiol, 108, 257, 10.1016/B978-0-12-410499-0.00010-1
Shen, 2014, Scar-modulating treatments for central nervous system injury, Neurosci Bull, 30, 967, 10.1007/s12264-013-1456-2
O'Shea, 2017, Cell biology of spinal cord injury and repair, J Clin Invest, 127, 3259, 10.1172/JCI90608
Buss, 2004, Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord, Brain, 127, 34, 10.1093/brain/awh001
Buss, 2009, NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury, BMC Neurol, 9, 32, 10.1186/1471-2377-9-32
Norenberg, 2004, The pathology of human spinal cord injury: defining the problems, J Neurotrauma, 21, 429, 10.1089/089771504323004575
Guest, 2005, Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury, Exp Neurol, 192, 384, 10.1016/j.expneurol.2004.11.033
Jones, 2003, The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury, Exp Neurol, 182, 399, 10.1016/S0014-4886(03)00087-6
Shen, 2009, PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration, Science, 326, 592, 10.1126/science.1178310
McKillop, 2013, Conditional Sox9 ablation reduces chondroitin sulfate proteoglycan levels and improves motor function following spinal cord injury, Glia, 61, 164, 10.1002/glia.22424
Takeuchi, 2013, Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injury, Nat Commun, 4, 10.1038/ncomms3740
Oudega, 2012, Systemic administration of a deoxyribozyme to xylosyltransferase-1 mRNA promotes recovery after a spinal cord contusion injury, Exp Neurol, 237, 170, 10.1016/j.expneurol.2012.06.006
Grimpe, 2004, A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord, Journal of Neuroscience, 24, 1393, 10.1523/JNEUROSCI.4986-03.2004
Bradbury, 2011, Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury, Brain Res. Bull, 84, 306, 10.1016/j.brainresbull.2010.06.015
Carter, 2008, The yellow fluorescent protein (YFP-H) mouse reveals neuroprotection as a novel mechanism underlying chondroitinase ABC-mediated repair after spinal cord injury, Journal of Neuroscience, 28, 14107, 10.1523/JNEUROSCI.2217-08.2008
Bartus, 2014, Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury, Journal of Neuroscience, 34, 4822, 10.1523/JNEUROSCI.4369-13.2014
Xu, 2018, Sox9 knockout mice have improved recovery following stroke, Exp Neurol, 303, 59, 10.1016/j.expneurol.2018.02.001
Didangelos, 2014, Regulation of IL-10 by chondroitinase ABC promotes a distinct Immune response following spinal cord injury, Journal of Neuroscience, 34, 16424, 10.1523/JNEUROSCI.2927-14.2014
Shechter, 2009, Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice, PLoS Med, 6, 10.1371/journal.pmed.1000113
Gensel, 2012, Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling, Cell Tissue Res, 349, 201, 10.1007/s00441-012-1425-5
Gensel, 2011, Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages, Expert Opin. Ther. Targets, 15, 505, 10.1517/14728222.2011.553605
Hesp, 2017, Proliferating NG2 cell-dependent angiogenesis and scar formation alter axon growth and functional recovery after spinal cord injury in mice, Journal of Neuroscience
Zhao, 2017, Mechanisms responsible for the inhibitory effects of epothilone B on scar formation after spinal cord injury, Neural Regen Res, 12, 478, 10.4103/1673-5374.202921
Ruschel, 2017, Systemic administration of epothilone D improves functional recovery of walking after rat spinal cord contusion injury, Exp Neurol
Sandner, 2018, Systemic epothilone D improves hindlimb function after spinal cord contusion injury in rats, Exp Neurol, 10.1016/j.expneurol.2018.01.018
Hao, 2017, Mechanisms underlying the promotion of functional recovery by deferoxamine after spinal cord injury in rats, Neural Regen Res, 12, 959, 10.4103/1673-5374.208591
Falnikar, 2015, Therapeutically targeting astrocytes with stem and progenitor cell transplantation following traumatic spinal cord injury, Brain Res, 1619, 91, 10.1016/j.brainres.2014.09.037
Hill, 2004, Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration, Exp Neurol, 190, 289, 10.1016/j.expneurol.2004.05.043
Xiao, 2016, One-year clinical study of NeuroRegen scaffold implantation following scar resection in complete chronic spinal cord injury patients, Sci China Life Sci, 59, 647, 10.1007/s11427-016-5080-z
Zhao, 2017, Clinical study of NeuroRegen scaffold combined with human mesenchymal stem cells for the repair of chronic complete spinal cord injury, Cell Transplant, 26, 891, 10.3727/096368917X695038
Haggerty, 2017, Extracellular matrix components as therapeutics for spinal cord injury, Neurosci Lett, 652, 50, 10.1016/j.neulet.2016.09.053
Kigerl, 2009, Toll-like receptors in spinal cord injury, Curr. Top. Microbiol. Immunol, 336, 121
Kigerl, 2014, Pattern recognition receptors and central nervous system repair, Exp Neurol, 258, 5, 10.1016/j.expneurol.2014.01.001
Sofroniew, 2009, Molecular dissection of reactive astrogliosis and glial scar formation, Trends Neurosci, 32, 638, 10.1016/j.tins.2009.08.002
David, 2011, Repertoire of microglial and macrophage responses after spinal cord injury, Nat Rev Neurosci, 12, 388, 10.1038/nrn3053
Gensel, 2015, Macrophage activation and its role in repair and pathology after spinal cord injury, Brain Res, 1619, 1, 10.1016/j.brainres.2014.12.045
Mabon, 2000, Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: a potential new anti-inflammatory treatment, Exp Neurol, 166, 52, 10.1006/exnr.2000.7488
Yang, 2004, Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury, Spine, 29, 966, 10.1097/00007632-200405010-00004
Kigerl, 2006, Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury, J Comp Neurol, 494, 578, 10.1002/cne.20827
Gensel JC, Popovich PG. Controversies on the role of inflammation in the injured spinal cord. In: Traumatic brain and spinal cord injury: challenges and developments in research. Morganti-Kossmann MC, Maas AI, Raghupathi R (Eds.). Cambrige Press, New York, 272–279.
de Castro, 2004, Evidence that infiltrating neutrophils do not release reactive oxygen species in the site of spinal cord injury, Exp Neurol, 190, 414, 10.1016/j.expneurol.2004.05.046
Kubota, 2012, Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury, Spine, 37, 1363, 10.1097/BRS.0b013e31824b9e77
Prüss, 2011, Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau, Brain Pathology (Zurich, Switzerland), 21, 652, 10.1111/j.1750-3639.2011.00488.x
Martinez, 2009, Alternative activation of macrophages: an immunologic functional perspective, Annu. Rev. Immunol, 27, 451, 10.1146/annurev.immunol.021908.132532
Gensel, 2009, Macrophages promote axon regeneration with concurrent neurotoxicity, Journal of Neuroscience, 29, 3956, 10.1523/JNEUROSCI.3992-08.2009
Greenhalgh, 2016, Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease, Brain Behav Immun, 10.1016/j.bbi.2016.04.013
Ren, 2013, Managing inflammation after spinal cord injury through manipulation of macrophage function, Neural Plasticity, 2013, 10.1155/2013/945034
Benowitz, 2011, Inflammation and axon regeneration, Curr. Opin. Neurol, 24, 577, 10.1097/WCO.0b013e32834c208d
Huang, 2014, Identification of distinct monocyte phenotypes and correlation with circulating cytokine profiles in acute response to spinal cord injury: a pilot study, PM&R, 6, 332, 10.1016/j.pmrj.2013.10.006
Kigerl, 2006, Drug evaluation: ProCord—a potential cell-based therapy for spinal cord injury, IDrugs, 9, 354
Rapalino, 1998, Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats, Nat Med, 4, 814, 10.1038/nm0798-814
Rabchevsky, 1997, Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth, J Neurosci Res, 47, 34, 10.1002/(SICI)1097-4547(19970101)47:1<34::AID-JNR4>3.0.CO;2-G
Bracken, 1990, A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study, N. Engl. J. Med, 322, 1405, 10.1056/NEJM199005173222001
Bowers, 2016, Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate, Neural Regen Res, 11, 882, 10.4103/1673-5374.184450
Geremia, 2012, CD11d antibody treatment improves recovery in spinal cord-injured mice, J Neurotrauma, 29, 539, 10.1089/neu.2011.1976
Bao, 2011, CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury, Exp Neurol, 231, 272, 10.1016/j.expneurol.2011.07.001
Shultz, 2013, Treatment with an anti-CD11d integrin antibody reduces neuroinflammation and improves outcome in a rat model of repeated concussion, J Neuroinflammation, 10, 26, 10.1186/1742-2094-10-26
Bao, 2012, A CD11d monoclonal antibody treatment reduces tissue injury and improves neurological outcome after fluid percussion brain injury in rats, J Neurotrauma, 29, 2375, 10.1089/neu.2012.2408
Saville, 2004, A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment, J Neuroimmunol, 156, 42, 10.1016/j.jneuroim.2004.07.002
Bao, 2005, Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats, J Neurochem, 94, 1361, 10.1111/j.1471-4159.2005.03280.x
Oatway, 2005, Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord, Journal of Neuroscience, 25, 637, 10.1523/JNEUROSCI.3960-04.2005
Gris, 2004, Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function, J Neurosci, 24, 4043, 10.1523/JNEUROSCI.5343-03.2004
Ditor, 2006, A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury, J Neurosurg Spine, 5, 343, 10.3171/spi.2006.5.4.343
Bao, 2004, Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats, J Neurochem, 88, 1335, 10.1046/j.1471-4159.2003.02240.x
Bao, 2012, The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade, J Neurotrauma, 29, 1626, 10.1089/neu.2011.2190
Fleming, 2008, Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function, Exp Neurol, 214, 147, 10.1016/j.expneurol.2008.04.024
Plemel, 2014, Immune modulatory therapies for spinal cord injury—past, present and future, Exp Neurol, 258, 91, 10.1016/j.expneurol.2014.01.025
Kwon, 2011, A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury, J Neurotrauma, 28, 1545, 10.1089/neu.2009.1149
Utagawa, 2008, Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats, Brain Res, 1207, 155, 10.1016/j.brainres.2008.02.057
Van Rooijen, 2010, Liposomes for specific depletion of macrophages from organs and tissues, Methods Mol Biol, 605, 189, 10.1007/978-1-60327-360-2_13
Iannotti, 2011, A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI, Exp Neurol, 230, 3, 10.1016/j.expneurol.2010.03.010
Horn, 2008, Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions, Journal of Neuroscience, 28, 9330, 10.1523/JNEUROSCI.2488-08.2008
Wu, 2018, Chloroquine promotes the recovery of acute spinal cord injury by inhibiting autophagy-associated inflammation and endoplasmic reticulum stress, J Neurotrauma, 10.1089/neu.2017.5414
Giulian, 1989, The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain, J Neurosci, 9, 4416, 10.1523/JNEUROSCI.09-12-04416.1989
Blight, 1994, Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage, Neuroscience, 60, 263, 10.1016/0306-4522(94)90220-8
Gensel, 2017, Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment, Sci. Rep, 7, 10.1038/srep40144
Jeong, 2017, Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice, Neurobiol Dis, 108, 73, 10.1016/j.nbd.2017.08.006
Evans, 2014, High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury, Exp Neurol, 254C, 109, 10.1016/j.expneurol.2014.01.013
Donnelly, 2011, Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages, Journal of Neuroscience, 31, 9910, 10.1523/JNEUROSCI.2114-11.2011
Saxena, 2016, Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges, Transl Res, 167, 152, 10.1016/j.trsl.2015.07.002
Polman, 2006, A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis, N. Engl. J. Med, 354, 899, 10.1056/NEJMoa044397
Elkins, 2017, Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial, Lancet Neurol, 16, 217, 10.1016/S1474-4422(16)30357-X
Hawthorne, 2011, Emerging concepts in myeloid cell biology after spinal cord injury, Neurotherapeutics, 8, 252, 10.1007/s13311-011-0032-6
Bomstein, 2003, Features of skin-coincubated macrophages that promote recovery from spinal cord injury, J Neuroimmunol, 142, 10, 10.1016/S0165-5728(03)00260-1
Ma, 2015, Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury, Brain Behav Immun, 45, 157, 10.1016/j.bbi.2014.11.007
Jones, 2010, A phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: pragmatics, recruitment, and demographics, Spinal Cord, 48, 798, 10.1038/sc.2010.29
Knoller, 2005, Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results, J Neurosurg Spine, 3, 173, 10.3171/spi.2005.3.3.0173
Lammertse, 2012, Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial, Spinal Cord, 50, 661, 10.1038/sc.2012.39
Lammertse, 2013, Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 International Spinal Cord Society Sir Ludwig Guttmann Lecture, Spinal Cord, 51, 2, 10.1038/sc.2012.137
Kong, 2017, Macrophage polarization: a key event in the secondary phase of acute spinal cord injury, J. Cell. Mol. Med, 21, 941, 10.1111/jcmm.13034
Cheng, 2016, Anti-inflammatory mechanism of neural stem cell transplantation in spinal cord injury, Int J Mol Sci, 17, 10.3390/ijms17091380
Francos-Quijorna, 2016, IL-4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injury, Glia, 64, 2079, 10.1002/glia.23041
Lima, 2017, Systemic interleukin-4 administration after spinal cord injury modulates inflammation and promotes neuroprotection, Pharmaceuticals (Basel), 10, 10.3390/ph10040083
Coll-Miró, 2016, Beneficial effects of IL-37 after spinal cord injury in mice, Proc Natl Acad Sci USA, 10.1073/pnas.1523212113
Dooley, 2016, Cell-based delivery of interleukin-13 directs alternative activation of macrophages resulting in improved functional outcome after spinal cord injury, Stem Cell Reports, 7, 1099, 10.1016/j.stemcr.2016.11.005
Guo, 2013, Granulocyte colony-stimulating factor improves alternative activation of microglia under microenvironment of spinal cord injury, Neuroscience, 238, 1, 10.1016/j.neuroscience.2013.01.047
Dooley, 2016, Interleukin-25 is detrimental for recovery after spinal cord injury in mice, J Neuroinflammation, 13, 101, 10.1186/s12974-016-0566-y
Guerrero, 2012, Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice, J Neuroinflammation, 9, 40, 10.1186/1742-2094-9-40
Mukaino, 2010, Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation, Exp Neurol, 224, 403, 10.1016/j.expneurol.2010.04.020
Okada, 2004, Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury, J Neurosci Res, 76, 265, 10.1002/jnr.20044
Esposito, 2011, Anti-TNF therapy in the injured spinal cord, Trends in Pharmacological Sciences, 32, 107, 10.1016/j.tips.2010.11.009
Saxena, 2015, Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury, ACS Nano, 9, 1492, 10.1021/nn505980z
Papa, 2016, Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury, Biomaterials, 75, 13, 10.1016/j.biomaterials.2015.10.015
Francos-Quijorna, 2017, Maresin 1 promotes inflammatory resolution, neuroprotection, and functional neurological recovery after spinal cord injury, Journal of Neuroscience, 37, 11731, 10.1523/JNEUROSCI.1395-17.2017
Zhang, 2017, Therapeutic potential of flavonoids in spinal cord injury, Rev Neurosci, 28, 87, 10.1515/revneuro-2016-0053
Ulndreaj, 2016, Modulating the immune response in spinal cord injury, Expert Rev Neurother, 16, 1127, 10.1080/14737175.2016.1207532
Orr, 2017, Compression decreases anatomical and functional recovery and alters inflammation after contusive spinal cord injury, J Neurotrauma, 34, 2342, 10.1089/neu.2016.4915